← Open Payments lookup

LILIAN ORUMANA: Open Payments

NPI 1457058091 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,497 in 124 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $1,237 · 2025 $2,497

Food & beverage: $2,497
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.12$356
ABBVIE INC.24$289
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$269
E.R. Squibb & Sons, L.L.C.9$237
Lundbeck LLC8$199
Biogen, Inc.9$194
Alkermes, Inc.7$193
Teva Pharmaceuticals USA, Inc.10$153
Almatica Pharma LLC6$137
Collegium Pharmaceutical, Inc.5$105

Products named: FANAPT, VRAYLAR, REXULTI, CAPLYTA, COBENFY, ZURZUVAE, ARISTADA, LOREEV XR.

Industry payments across AZ — which companies pay providers there.